Skip to main content
SpringerLink
Log in

Stereotactic Body Radiation Therapy: An Ablative Treatment Option for Primary and Secondary Liver Tumors

  • New Approaches to the Treatment of Hepatic Malignancies
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Only a subset of patients with primary and secondary liver tumors are eligible for surgical resection because of either the presence of extrahepatic disease, increased number of hepatic lesions, the anatomical distribution of tumors within the liver, and/or general medical inoperability. Nonsurgical, ablative tumor treatment may benefit selected patients by preserving normal liver function. This review presents the concept and technology of stereotactic body radiation therapy and summarizes available clinical data describing applications in the treatment of malignant liver tumors. We present predominantly peer-reviewed data but also summarize recent clinical developments along with discussions of current ongoing and planned multicenter studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Schneider PD. Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 1985;201:210–218.

    Article  PubMed  CAS  Google Scholar 

  2. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63–70.

    Article  PubMed  CAS  Google Scholar 

  3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.

    Article  PubMed  CAS  Google Scholar 

  4. Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002;137:1332–1339.

    Article  PubMed  Google Scholar 

  5. Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003;10:52–58.

    Article  PubMed  Google Scholar 

  6. McGhana JP, Dodd GD 3rd. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001;176:3–16.

    PubMed  CAS  Google Scholar 

  7. Ruers TJ, Joosten J, Jager GJ, Wobbes T. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 2001;88:844–849.

    Article  PubMed  CAS  Google Scholar 

  8. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy. Cancer 1999;85:1694–1702.

    Article  PubMed  CAS  Google Scholar 

  9. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000;89:276–284.

    Article  PubMed  CAS  Google Scholar 

  10. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159–166.

    Article  PubMed  CAS  Google Scholar 

  11. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600.

    PubMed  CAS  Google Scholar 

  12. Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003;228:335–345.

    Article  PubMed  Google Scholar 

  13. Timmerman R, Papiez L, Suntharalingam M. Extracranial stereotactic radiation delivery: expansion of technology beyond the brain. Technol Cancer Res Treat 2003;2:153–160.

    PubMed  Google Scholar 

  14. Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002;53:810–821.

    PubMed  Google Scholar 

  15. McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998;16:2246–2252.

    PubMed  CAS  Google Scholar 

  16. Pirzkall A, Debus J, Lohr F, et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. J Clin Oncol 1998;16:3563–3569.

    PubMed  CAS  Google Scholar 

  17. Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2003;57:452–464.

    Article  PubMed  Google Scholar 

  18. Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33:677–683.

    Article  PubMed  CAS  Google Scholar 

  19. Herfarth KK, Debus J, Lohr F, et al. Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 2000;46:329–335.

    Article  PubMed  CAS  Google Scholar 

  20. Lohr F, Debus J, Frank C, et al. Noninvasive patient fixation for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:521–527.

    PubMed  CAS  Google Scholar 

  21. Wulf J, Hadinger U, Oppitz U, Olshausen B, Flentje M. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 2000;57:225–236.

    Article  PubMed  CAS  Google Scholar 

  22. Lax I. Target dose versus extratarget dose in stereotactic radiosurgery. Acta Oncol 1993;32:453–457.

    Article  PubMed  CAS  Google Scholar 

  23. Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001;177:645–655.

    Article  PubMed  CAS  Google Scholar 

  24. Blomgren H, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1998;1:63–74.

    Article  Google Scholar 

  25. Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861–870.

    Article  PubMed  CAS  Google Scholar 

  26. Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19:164–170.

    PubMed  CAS  Google Scholar 

  27. Herfarth KK, Debus J, Lohr F, Bahner ML, Wannenmacher M. Stereotactic irradiation of liver metastases. Radiologe 2001;41:64–68.

    Article  PubMed  CAS  Google Scholar 

  28. Herfarth KK, Hof H, Bahner ML, et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 2003;57:444–451.

    Article  PubMed  Google Scholar 

  29. Schefter T, Gaspar LE, Kavanagh B, Ceronsky N, Feiner A, Stuhr K. Hypofractionated extracranial stereotactic radiotherapy for liver tumors. Int J Rad Onc Biol Phys 2003;57:S282.

    Google Scholar 

  30. Zimmermann F, Geinitz H, Schill S, Molls M. Erste Erfahrungen mit der stereotaktischen Strahlentherapie maligner Tumoren des Koerperstammes. Strahlenther Oncol 2002;178:S54.

    Google Scholar 

  31. Fuss M, Cavanaugh S, Thomas CR, Salter B. Daily stereotactic ultrasound targeting for intensity-modulated radiotherapy (IMRT) of abdominal malignancies. Proc ASCO 2003;22:346.

    Google Scholar 

  32. Fuss M, Salter B, Sadeghi A, et al. Stereotactic BAT ultrasound positioning for upper abdominal target volumes. Int J Rad Onc Biol Phys 2001;51:258.

    Google Scholar 

  33. Costantino T, Gilson B, Dimino E, et al. Extra-cranial stereotactic radiosurgery for hepatoma. Int J Rad Onc Biol Phys 2003;57:S281.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas

    Martin Fuss MD & Charles R. Thomas Jr. MD

  2. Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX, 78229

    Martin Fuss MD

Authors
  1. Martin Fuss MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles R. Thomas Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Fuss MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fuss, M., Thomas, C.R. Stereotactic Body Radiation Therapy: An Ablative Treatment Option for Primary and Secondary Liver Tumors. Ann Surg Oncol 11, 130–138 (2004). https://doi.org/10.1245/ASO.2004.10.907

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2004.10.907

Key Words

Search

Navigation